Alterity Therapeutics Ltd. has released a press release.
Appendix 4E and 2026 Annual Report
Earlier from Alterity Therapeutics
- Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
- Granted New U.S. Composition of Matter Patent for ATH434
- Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
- Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026